PRXi Pharmaceuticals Corporation appointed Gerrit Dispersyn, Dr. Med Sc. as Chief Development Officer effective April 24, 2017. Dr. Dispersyn will bring a wealth of experience to RXi in both clinical and product development. Dr. Pamela Pavco, RXi's current Chief Development Officer, is retiring. Effective May 19, 2017, Gerrit Dispersyn, Dr. Med. Sc. is an accomplished leader in clinical, product and business development. Dr. Dispersyn most recently served as the Vice President, Global Head of Clinical Affairs at Integra LifeSciences Corporation. In this role, Gerrit was responsible for Integra's global strategy and execution of Clinical Development, Clinical Operations and Medical Affairs projects and a member of Integra's Senior Management Leadership team, and several of the company's core teams for M&A projects.